The effects of the menstrual cycle, race, and gender on adrenergic receptors and agonists

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 1, 1996, Pages 99-104

  Mills, Paul J ^a   Ziegler, Michael G ^a   Nelesen, Richard A ^a   Kennedy, Brian P ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORSKOLIN; ISOPRENALINE;

ADULT; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; MENSTRUAL CYCLE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; RACE; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; SEX; THROMBOCYTE;

EID: 0029761798     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90172-1     Document Type: Article

References (32)

1. Feldman RD, Limbird LE, Nadeau J, Fitzgerald GA, Robertson D, Wood AJ. Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines. J Clin Invest 1983;72:164-70.
2. Aarons RD, Nies AS, Gerber JG, Molinoff PB. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther 1983;224:1-6.
3. Riemer R, Wu Y, Bottare S. Estrogen reduces β-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium. Mol Pharmacol 1988;33:389-95.
4. Geraghty D, Byrne K, McPherson G, Burcher E. Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats. Clin Exp Pharmacol Physiol 1990;17:567-78.
5. Cohen-Tannoudji J, Heilmann V, Legrand C, Maltier J. Regulation by progesterone of the high-affinity state of myometrial β-adrenergic receptor and of adenylate cyclase activity in the pregnant rat. J Mol Endocrinol 1991;6:137-45.
6. 1-adrenoceptors are detectable only in the midfollicular phase of the menstrual cycle. Clin Endocrinol Metab 1986;62:1220-6.
7. Jones SB, Bylund D, Rieser C, Shekim W, Byer J, Carr G. α-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther 1983;34:90-6.
8. Stowell L, McIntosh C, Cooke R, Ellis P. Adrenoceptor and imipramine receptor binding during the menstrual cycle. Acta Psychiatr Scand 1988;78:366-8.
9. Wheeldon NM, Newnham D, Coutie WJ, Peters JA, McDevitt DG, Lipworth BJ. Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol 1994;37:583-8.
10. 2-adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiologic variations of sex steroids. J Clin Endocrinol Metab 1984; 58:1068-76.
11. 2-adrenergic receptor binding and function during the menstrual cycle. J Psychiatr Res 1987;21:163-9.
12. Santala M, Vilska S, Saarikoski S, Castren O. Lymphocyte beta 2-adrenoceptor density during menstrual cycle and pregnancy, in delivery and puerperium. Eur J Obstet Gynecol Reprod Biol 1990;34:79-87.
13. Sundaresan PR, Madan MK, Kelvie SL, Weintraub M. Platelet alpha-2 adrenoceptors and the menstrual cycle. Clin Pharmacol Ther 1985;37:337-42.
14. Rutledge DR, Steinberg J, Cardozo L. Racial differences in drug response: isoproterenol effects on heart rate following intravenous metoprolol. Clin Pharmacol Ther 1989;45:380-6.
15. Venter C, Daya P, Joubert P, Strydom W. Ethnic differences in human lymphocyte cyclic AMP production after isoprenaline stimulation and propranolol blockade. Br J Clin Pharmacol 1985;19:187-90.
16. 2, and prostanoid receptor responses. Clin Pharmacol Ther 1990;47:360-5.
17. Johnson JA. Racial differences in lymphocyte β-adrenergic receptor sensitivity to propranolol. Life Sci 1993;53:297-304.
18. Rutledge DR. Are there β-adrenergic receptor response differences between racial groups? Ann Pharmacother 1991;25:824-34.
19. Metropolitan Life Foundation. 1983 Metropolitan height and weight tables. Stat Bull Metrop Insur Co 1983;64:1.
20. Roybyrne PP, Rubinow DR, Hoban CM, Stern R. Premenstrual changes: a comparison of five populations. Psychiatry Res 1986;17:77-85.
21. Mills PJ, Dimsdale JE, Ziegler MG, Hauger R, Nelesen RA, Brown M. Sympathetic alterations following sodium restriction and short-term captopril. J Am Coll Cardiol 1993;21:177-81.
22. Seamon K, Padgett W, Daly J. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci 1981;78:3363-7.
23. Kennedy B, Ziegler MG. A more sensitive radioenzymatic assay for catecholamines. Life Sci 1990;47:2143-53.
24. Halper JP, Mann JJ, Weksler ME, Bilezikian JP, Sweeney JA, Brown RP, et al. Beta adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effects of age and gender. Life Sci 1984;35:855-63.
25. Boulet A, Fortier M. Sex steroid regulation of β-adrenergic sensitive adenylate cyclase in rabbit myometrial cells in primary culture. Life Sci 1988;42: 829-40.
26. Harlan L, Coates R, Block G, Greenberg RS, Ershow A, Forman M, et al. Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiology 1993;4:25-31.
27. Elias EG, Suter CM, Brown SD, Buda BS, Vachon DA. Survival differences between black and white women with breast cancer. J Surg Oncol 1994;55:37-41.
28. Falkner B, Hulman S, Kushner H. Gender differences in insulin-stimulated glucose utilization among African-Americans. Am J Hypertens 1994;7:948-52.
29. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-42.
30. Mills PJ, Dimsdale JE, Ziegler M, Nelesen R. Racial differences in epinephrine and β-adrenergic receptors. Hypertension 1995;25:88-91.
31. Dimsdale J, Ziegler M, Graham R. The effect of hypertension, sodium, and race on isoproterenol sensitivity. Clin Exp Hypertens 1988;A10:747-56.
32. Isaacs K, Rossouw J, du Plooy WJ. Differences in lymphocyte beta-2-adrenoceptor density could explain reported differences in basal lymphocyte cAMP production in two ethnic groups. Med Sci Res 1993; 21:313-4.